Jun. 23 at 2:28 AM
$SLS $ABBV $PFE $PFE I am more excited about the bidding war behind the scenes than ever before because in last few months We have seen a floor set for a bare minimum single potential Blockbuster phase 3 drug asset at
$10 Billion.
What are the true implications of an Oncology Platforms that can tackle 40+ different cancer types with an unprecedented Ad Infinitum Dosage schedule for 3 plus year with CURATIVE outcome?
First comes the Trigger 80Th event that triggers the Top line data for Regal Pivotal Registrational phase 3.
My Long Brothers and Sisters I have moved past charting and modeling scenarios to final valuation of this juggernaut unfolding right before our own eyes. Be encouraged by what’s going on in the Biotechnology sector. Last week we saw 10 deals. First day of the week today, We already saw the biggest acquisition by AbbVie in an over a decade.
SLS Valuation will Top
$50 Billion when the bidding war is over. Mark this post, it’s coming sooner than you all think ✌️🙏❤️🩹
